NFE2L2 and osteoporosis: Both in vivo and in vitro studies have confirmed that gastrodin reduces glucocorticoid induced cell apoptosis and increases mitochondrial membrane function by activating the NRF2/HO-1 pathway, inhibits ferroptosis of osteoblasts, enhances differentiation function of osteoblasts, and thus achieves the effect of improving osteoporosis [93].